Alcohol interactions with drugs and its effect on the treatment of skin diseases

Clinics in Dermatology

Volumn 17, Issue 4, 1999, Pages 443-445

  Zachariae, Hugh ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ALDEHYDE DEHYDROGENASE; ANTIHISTAMINIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CALCIUM ANTAGONIST; CHLORPROPAMIDE; CYCLOSPORIN; DISULFIRAM; ETRETIN; ETRETINATE; GRISEOFULVIN; METHOTREXATE; METRONIDAZOLE; RETINOID; TOLBUTAMIDE; VERAPAMIL;

ADVERSE DRUG REACTION; ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ALCOHOL WITHDRAWAL; CONFERENCE PAPER; DRUG ALCOHOL INTERACTION; FLUSHING; HUMAN; LIVER TOXICITY; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; PUVA; SKIN DISEASE;

ALCOHOL DRINKING; DERMATOLOGIC AGENTS; DRUG INTERACTIONS; ETHANOL; HUMANS; LIVER; METHOTREXATE; PSORIASIS;

EID: 0032877826     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(99)00030-9     Document Type: Conference Paper

References (34)

1. Dreyer L., Winther J., Andersen A., et al. Avoidable cancers in the Nordic countries Alcohol consumption . APMIS Suppl. 76:1997;48-67.
2. Margolis J., Roberts D. Frequency of skin lesions in chronic drinkers. Arch Dermatol. 112:1976;1326-1327.
3. Grosshans E. Skin dermatoses in alcoholics. Arch Dermatol. 113:1977;1734.
4. Rothenborg H., Andersen H. Alcohol and skin disorders. J Eur Acad Dermatol Venereol. 2:1993;113-120.
5. Zachariae H. Management of difficult psoriasis. Champion R., Pye R. Recent advances in dermatology. 1990;1-20 Churchill Livingstone, Edinburgh.
6. Goedde H., Agarwal D., Harada S. Genetic studies on alcohol-metabolising enzymes Detection of isoenzymes in human hair roots . Enzyme. 25:1980;281-286.
7. Wilkin J. Flushing disorders. In: Mitchell Sams W, Lynch P, editors. Principles and practice of dermatology. New York: Churchill Livingstone, 1990, 495-500.
8. Barnett A., Gonzalez-Auvert C., Pyke D., et al. Blood concentrations of acetaldehyde during chlorpropamide-alcohol flush. BMJ. 283:1981;939-941.
9. Leslie R., Barnett A., Pyke D. Chlorpropamide alcohol flushing and diabetic retinopathy. Lancet. 1:1979;997-999.
10. Tan O., Stafford R., Sarkany I., et al. Suppression of alcohol-induced flushing by a combination of H1 and H2 histamine antagonists. Br J Dermatol. 107:1982;647-652.
11. Uri J, Parks D. Disulfiram-like reaction to certain cephalosporins. Ther Drug Monit 1983;5:219-24.
12. Czarnetsky B. Urticaria. 1986;90-93 Springer-Verlag, Berlin.
13. Roenigk H., Auerbach R., Maibach H., et al. Methotrexate in psoriasis Revised guidelines . J Am Acad Dermatol. 19:1988;145-156.
14. Coe R., Bull F. Cirrhosis associated with methotrexate treatment of psoriasis. JAMA. 206:1969;1515-1520.
15. Epstein E., Craft J. Cirrhosis following methotrexate administration for psoriasis. Arch Dermatol. 100:1969;531.
16. Weinstein G., Roenigk H., Maibach H., et al. Psoriasis-liver-methotrexate interactions. Arch Dermatol. 108:1973;36-42.
17. Robinson J., Baughman R., Auerbach R., et al. Methotrexate hepatotoxicity in psoriasis. Arch Dermatol. 110:1980;413-415.
18. Nyfors A. Benefits and adverse drug experiences during long-term methotrexate treatment of 248 psoriatics. Dan Med Bull. 25:1978;208-211.
19. Zachariae H., Grunnet E., Søgaard H. Liver biopsies in methotrexate-treated patients - a re-evaluation. Acta Derm Venereol (Stockh). 55:1975;291-296.
20. Barak A., Tuma D., Beckenhauer H. Methotrexate hepatoxicity. J Am Coll Nutr. 3:1984;93-96.
21. Zachariae H., Søgaard H. Methotrexate-induced liver cirrhosis A follow-up . Dermatologica. 175:1987;178-182.
22. Grunnet E. Alcohol consumption in psoriasis. Dermatologica. 149:1974;136-139.
23. Whitting-O'Keefe Q., Fye K., Sach K. Methotrexate and histologic hepatic abnormalities A meta-analysis . Am J Med. 90:1991;711-716.
24. Poikolainen K., Reunala T., Karvonen J., et al. Alcohol intake A risk factor for psoriasis in young and middle-aged men? BMJ. 300:1990;780-783.
25. Braathen L., Botten G., Bjerkedal T. Psoriatics in Norway. A questionnaire study on health status, contact with paramedical professions, and alcohol and tobacco consumption. Acta Derm Venereol Suppl (Stockh). 142:1989;9-12.
26. Morse R., Perry H., Hurt R. Alcoholism and psoriasis. Alcohol Clin Exp Res. 9:1985;396-399.
27. Larsen F.G., Jacobsen P., Knudsen J., et al. Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol. J Invest Dermatol. 100:1993;623-627.
28. Lambert W., Meyer E., De Leenheer A., et al. Pharmacokinetics and drug interactions of etretinate and acitretin. J Am Acad Dermatol. 27:1992;S19-S22.
29. Zachariae H. Dangers of methotrexate/etretinate combination therapy. Lancet. 1:1988;422.
30. Glazer S., Roenigk H., Yokoo H., et al. Ultrastructural survey and tissue analysis of human livers after a 6-month course of etretinate. J Am Acad Dermatol. 10:1984;632-638.
31. Camuto P., Shupack J., Orbuch P., et al. Long-term effects of etretinate on the liver in psoriasis. Am J Surg Pathol. 11:1987;30-37.
32. Tucker H. Clinical and laboratory tolerance studies in volunteers given oral methoxalen. J Invest Dermatol. 32:1959;277-280.
33. Freeman K., Warin P. Deterioration of liver function during PUVA therapy. Photodermatology. 1:1984;147-148.
34. Dul B., Gajkowska B. The influence of ethanol and the calcium channel antagonist nifedipine on myocardial ultrastructure in the rat. Exp Toxicol Pathol. 50:1998;27-30.